10-(1,1':3',1''-Terphenyl-5'-yl)anthracene-9-boronic acid, 99+%, 1g

Methyl (R)-4-(1-hydroxyethyl)benzoate, 1g

3-(Difluoromethyl)bicyclo[1.1.1]pentan-1-amine hydrochloride, 98%, 1g

4,7-Dibromo-5-fluoro-2,1,3-benzothiadiazole, 95.0%, 5g

3-aminobenzoic acid, >=98%, for synthesis, 250 g, plastic packaging.

4-(Pyridin-3-yl)thiazole, 95.0%, 100mg

1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione, 98.0%, 10g

3-(Oxazol-4-yl)benzonitrile, 5g

(6-(Methoxycarbonyl)pyridin-3-yl)boronic acid, 95.0%, 1g

tert-Butyl 2,2-dimethylpiperazine-1-carboxylate, 98.0%, 5g

(1R,6S,8R)-3-azabicyclo[4.2.0]octane-8-carboxylic acid hydrochloride, 95.0%, 250mg

(4-((3-Bromophenyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

tert-Butyl 3-amino-3-thioxopropanoate, 97%, 250mg